SCHEMBL13844442

SCHEMBL13844442

CCOc1cc2c(-c3nnnn3Cc3cccc(N)c3)ncnc2cc1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 2/20 0.43
RET P07949 1/20 0.43
KDR P35968 1/20 0.43
ENPP1 P22413 1/20 0.43
EGFR P00533 2/20 0.39
PDGFRB P09619 2/20 0.39
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
ERBB2 P04626 2/20 0.39
ACHE P22303 1/20 0.38
BACE1 P56817 1/20 0.38
P2RX7 Q99572 1/20 0.38
HTT P42858 2/20 0.37
IRAK1 P51617 1/20 0.37
IRAK4 Q9NWZ3 1/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2833476 0.96 EGFR (0.39) KITRETKDREGFRTSHR
SCHEMBL2831983 0.95 KIT (0.47) KITRETKDREGFRPDGFRB
Hydrochloric Acid SCHEMBL2833456 0.94 KIT (0.46) KITRETKDREGFRALDH1A1
SCHEMBL2837582 0.89 EGFR (0.42) KITRETKDRENPP1EGFR
SCHEMBL16507592 0.86 EGFR (0.53) KITEGFRALDH1A1ERBB2ACHE
SCHEMBL2836761 0.83 ABCG2 (0.43) EGFRPDGFRBALDH1A1LMNAHPGD
SCHEMBL13090429 0.81 ERBB2 (0.43) RETKDREGFRPDGFRBALDH1A1
SCHEMBL2834365 0.81 ABCG2 (0.51) EGFRPDGFRBALDH1A1ERBB2ACHE
SCHEMBL2836110 0.77 P2RX7 (0.44) ENPP1EGFRERBB2P2RX7FBP1
SCHEMBL2830929 0.76 ABCG2 (0.44) ENPP1EGFRPDGFRBALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009057139-A2 NOVEL 4-(TETRAZOL-5-YL)-QUINAZOLINE DERIVATIVES AS ANTI CANCER AGENTS NATCO PHARMA LIMITED (IN) 2009-05-07 WO disclosed